Opus Genetics, Inc.
OPGx-LCA5
Countdown
633days
Catalyst readout · ~ Mar 31, 2028 estimated
What's at stake
A key catalyst for OPGx-LCA5 (its lead indication) is expected ~ Mar 31, 2028.
Primary source
· SEC 8-K
verified 14h ago
“a third tranche of $25 million will be funded upon the FDA Application Acceptance Date for OPGx-LCA5 on or prior to March 31, 2028.”